Plasma Hyperosmolality Prolongs QTc Interval and Increases Risk for Atrial Fibrillation in Traumatic Brain Injury Patients

Introduction: Hyperosmotic therapy with mannitol is frequently used for treatment cerebral edema, and 320 mOsm/kg H(2)O has been recommended as a high limit for therapeutic plasma osmolality. However, plasma hyperosmolality may impair cardiac function, increasing the risk of cardiac events. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Dabrowski, Wojciech, Siwicka-Gieroba, Dorota, Robba, Chiara, Badenes, Rafael, Bialy, Mateusz, Iwaniuk, Paulina, Schlegel, Todd T, Jaroszynski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288326/
https://www.ncbi.nlm.nih.gov/pubmed/32365845
http://dx.doi.org/10.3390/jcm9051293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288326/
https://www.ncbi.nlm.nih.gov/pubmed/32365845
http://dx.doi.org/10.3390/jcm9051293

Ejemplares similares